NEW YORK & CAMBRIDGE, Mass.–(BUSINESS WIRE)–March 11, 2021– In a Series A round, Covid Apollo announces its investment in Rhinostics, an early-stage company that provides a novel solution of enabling comfortable sample collection, rapid accessioning, and automated cap removal that can be linked to high throughput Covid-19 assays to remove wasted time, headcount and costs […]
Home »